Displaying items by tag: AJX

ASX VENDOR ANNOUNCEMENT: Alexium International (ASX: AJX) has signed a Supply and Evaluation Agreement with US$15 billion Israel Chemicals Ltd (TASE/NYSE: ICL) for the market launch of Alexiflam® NF.

ASX VENDOR ANNOUNCEMENT: Alexium International (ASX: AJX) has signed a Supply and Evaluation Agreement with US$15 billion Israel Chemicals Ltd (TASE/NYSE: ICL) for the market launch of Alexiflam® NF.

Published in Health

Subscribe to Newsletter

*  Enter the security code shown: img0

CYBERSECURITY

PEOPLE MOVES

GUEST ARTICLES

Guest Opinion

ITWIRETV & INTERVIEWS

RESEARCH & CASE STUDIES

Channel News

Comments